1. Home
  2. WKEY vs PLRX Comparison

WKEY vs PLRX Comparison

Compare WKEY & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$8.11

Market Cap

83.5M

Sector

Technology

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
PLRX
Founded
1999
2015
Country
Switzerland
United States
Employees
102
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
74.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WKEY
PLRX
Price
$8.11
$1.23
Analyst Decision
Strong Buy
Hold
Analyst Count
2
4
Target Price
$10.50
$2.67
AVG Volume (30 Days)
85.8K
463.6K
Earning Date
01-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.22
N/A
Revenue Next Year
$91.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$1.09
52 Week High
$19.80
$1.95

Technical Indicators

Market Signals
Indicator
WKEY
PLRX
Relative Strength Index (RSI) 59.76 48.03
Support Level $7.39 $1.14
Resistance Level $8.22 $1.37
Average True Range (ATR) 0.58 0.06
MACD 0.02 -0.00
Stochastic Oscillator 65.40 38.64

Price Performance

Historical Comparison
WKEY
PLRX

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: